Celldex Therapeutics, Inc. · NASDAQ:CLDX

T. Rowe Price Associates Inc reported a 6.00% stake in Celldex Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Aug 14, 2026

T. Rowe Price Associates Inc reported a 6.00% stake in Celldex Therapeutics, Inc., 4,686,187 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).

Stake
6.00%
Shares
4,686,187
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.6.00%4,686,187

Source

View original at SEC

Related